RENEW Scleroderma: A Peer-Mentored, Web Intervention for Resilience-based, Energy Management to Enhance Wellbeing and Fatigue
NCT04908943 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 174
Last updated 2023-11-30
Summary
The researchers seek to understand if the Resilience-based, Energy Management to Enhance Wellbeing and Fatigue (RENEW) program helps with scleroderma symptom management and disease burden. The researchers think that those participants who receive the intervention will have clinically meaningful changes of symptom management and disease burden.
Conditions
- Scleroderma
Interventions
- BEHAVIORAL
-
RENEW
RENEW is a 12-week, peer-led, web-based program to help people with scleroderma learn skills that can be used to manage disease symptoms and improve well-being.
Sponsors & Collaborators
-
Rheumatology Research Foundation
collaborator OTHER - lead OTHER
Principal Investigators
-
Susan Murphy · University of Michigan
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-08-28
- Primary Completion
- 2023-05-29
- Completion
- 2023-05-29
Countries
- United States
Study Locations
More Related Trials
-
Taking Charge of Systemic Sclerosis
NCT02494401 ·Status: COMPLETED ·Phase: NA
-
Scleroderma Patient-centered Intervention Network (SPIN) Hand Program
NCT03419208 ·Status: COMPLETED ·Phase: NA
-
Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis
NCT05177380 ·Status: UNKNOWN ·Phase: NA
-
Stem Cell Factor, a Potential Biological Marker of Skin Involvement in Systemic Sclerosis?
NCT05482594 ·Status: UNKNOWN
-
The Effects of Exercise in Patients With Systemic Sclerosis
NCT03058887 ·Status: COMPLETED ·Phase: NA
-
A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms
NCT05559580 ·Status: COMPLETED ·Phase: PHASE2
-
Exercise in People With Systemic Sclerosis
NCT05234671 ·Status: COMPLETED ·Phase: NA
-
Platform Clinical Study for Conquering Scleroderma
NCT06195072 ·Status: RECRUITING ·Phase: PHASE2
-
SPIN Self-Management Feasibility Trial With Progression to Full-scale Trial (SPIN-SELF)
NCT04246528 ·Status: COMPLETED ·Phase: NA
-
Optical Elastography of Systemic Sclerosis Skin
NCT02835196 ·Status: COMPLETED
-
Scleroderma Patient-centered Intervention Network (SPIN) Hand Program Feasibility Study
NCT03092024 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of a Home-based, Self-administered Exercise Program for Hands in Patients With Systemic Sclerosis
NCT04481984 ·Status: COMPLETED ·Phase: NA
-
Exercise With Scleroderma Functional Outcomes
NCT06425653 ·Status: COMPLETED ·Phase: NA
-
Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
NCT02349009 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
NCT01743612 ·Status: COMPLETED ·Phase: NA
-
Western Sweden Systemic Sclerosis Project
NCT07345052 ·Status: RECRUITING
-
Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis
NCT00667134 ·Status: COMPLETED
-
Systemic Sclerosis Clinical and Biomarker Study
NCT02531009 ·Status: WITHDRAWN
-
The Effects of Telerehabilitation Based Exercise Program in Patients With Systemic Sclerosis
NCT05078749 ·Status: UNKNOWN ·Phase: NA
-
SPIN Self-Management Feasibility Trial
NCT03914781 ·Status: COMPLETED ·Phase: NA
-
Delving Into Participation Trends of Scleroderma Clinical Trials
NCT06264492 ·Status: NOT_YET_RECRUITING
-
Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis
NCT02212249 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)
NCT00442611 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Periodontal Microbiota in Systemic Sclerosis
NCT06182293 ·Status: RECRUITING ·Phase: NA
-
Scleroderma: Functional Disability Between the Dominant and Contralateral Hand.
NCT05171114 ·Status: COMPLETED ·Phase: NA